Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis.

AIMS To evaluate the value of (18)F-fluoro-2-deoxyglucose positron emission tomography ((18)F-FDG PET) in detecting cardiac sarcoidosis. METHODS AND RESULTS Thirty-two patients with sarcoidosis and thirty controls were recruited. All subjects underwent cardiac (18)F-FDG PET after a 6 h fasting period, and subjects with sarcoidosis underwent blood testing, ECG, echocardiography, and (67)Ga and (99m)Tc-sestamibi (MIBI) scintigraphy. We classified (18)F-FDG PET images into four patterns ('none', 'diffuse', 'focal', and 'focal on diffuse') and found that all the control subjects exhibited either none (n=16) or diffuse (n=14) pattern. In contrast, fifteen subjects with sarcoidosis exhibited none, seven exhibited diffuse, eight exhibited focal, and two exhibited focal on diffuse patterns, with the prevalence of the focal and focal on diffuse patterns being significantly higher in the sarcoidosis group when compared with the control group (P<0.001). None of the 32 subjects with sarcoidosis exhibited abnormal findings on (67)Ga scintigraphy, and 4 exhibited abnormal findings on (99m)Tc-MIBI scintigraphy. CONCLUSION Focal uptake of the heart on (18)F-FDG PET images is a characteristic feature of patients with sarcoidosis. Furthermore, (18)F-FDG PET has the potential to detect cardiac sarcoidosis that cannot be diagnosed by (67)Ga or (99m)Tc-MIBI scintigraphy.

[1]  C. Rhodes,et al.  Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography , 1994, European Journal of Nuclear Medicine.

[2]  Joseph K. T. Lee,et al.  Imaging manifestations of abdominal sarcoidosis. , 2004, AJR. American journal of roentgenology.

[3]  Pamela S Douglas,et al.  Acc/aha/ase 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article a Report of the American College of Cardiology/american Heart Association Task Force on Practice Guidelines (acc/aha/ase Committee to Update the 1997 Guidelines for the Clinical Application of Echocar , 2003 .

[4]  D. Faxon,et al.  ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echoca , 2003, Journal of the American College of Cardiology.

[5]  M. Yoshiyama,et al.  Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  F. Melichar,et al.  18F-fluorodeoxyglucose accumulation in the heart, brain and skeletal muscle of rats; the influence of time after injection, depressed lipid metabolism and glucose-insulin. , 2001, Nuclear medicine review. Central & Eastern Europe.

[7]  H. Hishida,et al.  Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. , 1999, American heart journal.

[8]  Ramesh S Gulrajani,et al.  The evolutional stage changes in sarcoidosis on gallium-67 scintigraphy , 1998, Annals of nuclear medicine.

[9]  L. Newman,et al.  Medical progress : Sarcoidosis , 1997 .

[10]  A. Jula,et al.  Insulin action on heart and skeletal muscle glucose uptake in essential hypertension. , 1995, The Journal of clinical investigation.

[11]  K. Chida,et al.  Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. , 1995, Chest.

[12]  S L Bacharach,et al.  Artifactual inhomogeneities in myocardial PET and SPECT scans in normal subjects. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  P. Lewis,et al.  Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  T. Suzuki,et al.  Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. , 1994, Chest.

[15]  T Ido,et al.  Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  U Ruotsalainen,et al.  Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. , 1992, The Journal of clinical investigation.

[17]  A. Alavi,et al.  Gallium-67-citrate scanning in the assessment of disease activity in sarcoidosis. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  F. Fazio,et al.  Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  R. P. Spencer,et al.  Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  K. Bailey,et al.  Two-dimensional echocardiographic findings in systemic sarcoidosis. , 1989, The American journal of cardiology.

[21]  M. Phelps,et al.  Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography. , 1986, Journal of the American College of Cardiology.

[22]  D. Morris,et al.  Metabolic fate of extracted glucose in normal human myocardium. , 1985, The Journal of clinical investigation.

[23]  J. Barrio,et al.  Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. , 1985, Journal of the American College of Cardiology.

[24]  Y. Koiwaya,et al.  Steroid therapy in cardiac sarcoidosis. Increased left ventricular contractility concomitant with electrocardiographic improvement after prednisolone. , 1984, Chest.

[25]  P. Bjerle,et al.  ECG abnormalities in patients with sarcoidosis. , 2009, Acta medica Scandinavica.

[26]  M E Phelps,et al.  Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  G. Hutchins,et al.  Cardiac Sarcoid: A Clinicopathologic Study of 84 Unselected Patients with Systemic Sarcoidosis , 1978, Circulation.

[28]  J. Mason,et al.  Cardiac sarcoidosis: Diagnosis with endomyocardial biopsy and treatment with corticosteroids☆ , 1978 .

[29]  W. Roberts Sarcoidosis of the heart , 1978 .

[30]  W. Roberts,et al.  Sarcoidosis of the heart: A clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II) , 1977 .

[31]  K. Iwai,et al.  CLINICOPATHOLOGICAL STUDY ON FATAL MYOCARDIAL SARCOIDOSIS * , 1976, Annals of the New York Academy of Sciences.